UTP11L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.416000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.176600E-01
Normal-vs-Stage2
8.062800E-01
Normal-vs-Stage3
8.140400E-01
Normal-vs-Stage4
2.076400E-01
Stage1-vs-Stage2
3.813200E-01
Stage1-vs-Stage3
9.386200E-01
Stage1-vs-Stage4
4.214000E-02
Stage2-vs-Stage3
5.290200E-01
Stage2-vs-Stage4
2.868200E-01
Stage3-vs-Stage4
2.150800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.586800E-01
Normal-vs-AfricanAmerican
5.344600E-01
Normal-vs-Asian
9.591000E-01
Caucasian-vs-AfricanAmerican
6.239000E-01
Caucasian-vs-Asian
7.977400E-01
AfricanAmerican-vs-Asian
4.488000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.187200E-01
Normal-vs-Female
7.292600E-01
Male-vs-Female
4.090800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.018000E-01
Normal-vs-Age(41-60Yrs)
5.654000E-01
Normal-vs-Age(61-80Yrs)
9.254400E-01
Normal-vs-Age(81-100Yrs)
5.008000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.383600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.941400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.728800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.010840E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.496100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.042630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.807600E-01
Normal-vs-Daily Drinker
7.822800E-01
Normal-vs-Weekly Drinker
7.747800E-01
Normal-vs-Occasional Drinker
5.400200E-01
Normal-vs-Social Drinker
8.698600E-01
Non Drinker-vs-Daily Drinker
6.314800E-01
Non Drinker-vs-Weekly Drinker
2.224400E-01
Non Drinker-vs-Occasional Drinker
2.677700E-02
Non Drinker-vs-Social Drinker
1.775560E-01
Daily Drinker-vs-Weekly Drinker
3.067000E-01
Daily Drinker-vs-Occasional Drinker
1.281770E-01
Daily Drinker-vs-Social Drinker
4.237400E-01
Weekly Drinker-vs-Occasional Drinker
9.733800E-01
Weekly Drinker-vs-Social Drinker
7.073200E-01
Occasional Drinker-vs-Social Drinker
5.432600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.804000E-01
Normal-vs-Grade 2
8.367000E-01
Normal-vs-Grade 3
7.940800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.717430E-01
Grade 1-vs-Grade 3
7.371400E-01
Grade 1-vs-Grade 4
7.804000E-01
Grade 2-vs-Grade 3
7.675800E-02
Grade 2-vs-Grade 4
8.367000E-01
Grade 3-vs-Grade 4
7.940800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.715400E-01
Normal-vs-NonDiabetic
8.977400E-01
Diabetic-vs-NonDiabetic
2.111000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.386000E-01
Normal-vs-NoPancreatitis
9.379400E-01
Pancreatitis-vs-NoPancreatitis
6.171200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.986600E-01
Normal-vs-N1
7.640800E-01
N0-vs-N1
2.158000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.723200E-01
Normal-vs-TP53-NonMutant
9.876000E-01
TP53-Mutant-vs-TP53-NonMutant
1.392240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
